Compare GSK plc (GSK) vs Invesco WilderHill Clean Energy ETF (PBW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Invesco WilderHill Clean Energy ETF — how do they compare? GSK plc trades at $46.5 (market cap $91.88B), while Invesco WilderHill Clean Energy ETF trades at $28.33 (market cap $335.90M). The key difference: GSK plc is far larger — about 273.5× Invesco WilderHill Clean Energy ETF's market cap, and GSK plc pays a 3.9% dividend while Invesco WilderHill Clean Energy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Invesco WilderHill Clean Energy ETF for 46 Days on average.
| GSK | PBW | |
|---|---|---|
Market Cap | $91.88B | $335.90M |
Volume | 7,730,529 | 628,890 |
Sector | Health | Sector/Thematic |
52-Week High | $61.18 | $46.99 |
52-Week Low | $43.24 | $28.29 |
Typical Hold Time | 93 Days | 46 Days |
Enterprise Value | $111.88B | — |
Dividend Yield | 3.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.54, down 1.02% with bearish technical signals but strong fundamentals including 29.73% ROE and consistent earnings beats. The company maintains robust profitability with 72.73% gross margins and is actively expanding its oncology pipeline through strategic partnerships. Recent developments include a $750M cancer therapy acquisition and advancing mRNA vaccine candidates.
GSK presents a mixed outlook with strong operational performance offset by technical weakness. Investment appeal lies in valuation multiples below industry averages and pipeline expansion, though risks include HIV patent expirations and manufacturing restructuring. Analyst consensus leans cautious with 55% hold ratings amid near-term headwinds.
PBW (Invesco WilderHill Clean Energy ETF) trades at $28.33, down 2.04% with a bearish technical signal. The ETF's unique selection criteria prioritize ecological factors over financial metrics, resulting in concentrated exposure to clean energy companies. Recent institutional selling by IFP Advisors (-96.3% position) reflects caution amid sector volatility. Technical indicators show mixed signals with neutral oscillators but bearish moving averages.
Clean energy ETFs face headwinds from oil price volatility and tech sector weakness, though long-term energy transition trends provide growth potential. Key risks include undiversified portfolio concentration, geopolitical energy market impacts, and Federal Reserve policy uncertainty. The ETF's performance remains tied to clean energy adoption rates and government policy support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Invesco WilderHill Clean Energy ETF
PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →
